Review: taking Claritin and Ephedrine together


Summary

Drug interactions are reported among people who take Claritin and Ephedrine together. This review analyzes the effectiveness and drug interactions between Claritin and Ephedrine. It is created by eHealthMe based on reports of 73 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Claritin

Claritin has active ingredients of loratadine. It is often used in hypersensitivity. (latest outcomes from Claritin 38,014 users)

Ephedrine

Ephedrine has active ingredients of ephedra. It is often used in hypotension. (latest outcomes from Ephedrine 1,121 users)

On Sep, 19, 2016

73 people who take Claritin, Ephedrine are studied.


Number of reports submitted per year:

Claritin and Ephedrine drug interactions.

Drug effectiveness over time:

Claritin:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Ephedrine:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Claritin:
  • female: 50.0% - (1 of 2 people)
  • male: 0.0% - (0 of 0 people)
Ephedrine:
  • female: 50.0% - (1 of 2 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Claritin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Ephedrine:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • cerebral infarction
  • hypoaesthesia
  • pulmonary embolism
  • pyrexia
  • abdominal distension
  • abdominal pain
  • blood glucose increased
  • blood pressure increased
  • cardiac arrest
  • cholecystitis
1 - 6 months:
  • blood creatinine increased
  • atrial fibrillation
  • renal failure acute
  • leukopenia
  • sepsis
  • systemic inflammatory response syndrome
  • tinnitus
6 - 12 months:
  • gait disturbance
  • hypoaesthesia
  • insomnia
  • malaise
  • mobility decreased
  • peripheral swelling
  • peroneal nerve palsy
  • dizziness
  • decreased appetite
  • fall
2 - 5 years:
  • tinnitus
5 - 10 years:
  • dry skin
  • premature aging
10+ years:
  • atrial fibrillation
  • leukopenia
  • sepsis
  • systemic inflammatory response syndrome
not specified:
  • abdominal discomfort
  • hypothyroidism
  • diarrhoea
  • gastrooesophageal reflux disease
  • abdominal pain
  • abdominal wall mass
  • conjunctivitis
  • eustachian tube dysfunction
  • gallbladder polyp
  • lymphoma

Most common drug interactions by gender *:

female:
  • diarrhoea
  • abdominal discomfort
  • gastrooesophageal reflux disease
  • hypothyroidism
  • abdominal wall mass
  • conjunctivitis
  • eustachian tube dysfunction
  • gallbladder polyp
  • lymphoma
  • myeloproliferative disorder
male:
  • nausea
  • vomiting
  • cerebral infarction
  • muscle spasms
  • blood creatinine increased
  • insomnia
  • abdominal discomfort
  • alcohol poisoning
  • anxiety
  • atrial fibrillation

Most common drug interactions by age *:

10-19:
  • abdominal distension
  • abdominal pain upper
  • benign lymph node neoplasm
  • biliary colic
  • cholecystitis chronic
  • cholelithiasis
  • decreased appetite
  • diarrhoea
  • epigastric discomfort
  • flatulence
30-39:
  • deep vein thrombosis
  • dry skin
  • fatigue
  • hypersomnia
  • hypoaesthesia
  • paraesthesia
  • premature aging
  • somnolence
40-49:
  • gastrooesophageal reflux disease
  • hypothyroidism
  • abdominal discomfort
  • abdominal pain
  • abdominal wall mass
  • blood cholesterol increased
  • breast calcifications
  • breast mass
  • conjunctivitis
  • diarrhoea
50-59:
  • asthma
  • cough
  • dyspnoea
  • maculopathy
  • retinal degeneration
  • abdominal distension
  • abdominal pain
  • cholecystitis
  • cholecystitis infective
  • gallbladder enlargement
60+:
  • nausea
  • vomiting
  • atrial fibrillation
  • insomnia
  • muscle spasms
  • blood creatinine increased
  • pyrexia
  • abdominal discomfort
  • anaemia
  • blood pressure decreased

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Claritin and Ephedrine?

Can you answer these questions?

More questions for: Claritin, Ephedrine

You may be interested in these reviews

More reviews for: Claritin, Ephedrine

On eHealthMe, Claritin (loratadine) is often used to treat hypersensitivity. Ephedrine (ephedra) is often used to treat hypotension. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.